NetApp reports Q1 beat; Citi hikes price target
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: Only post material that’s relevant to the topic being discussed. Avoid profanity, slander or personal attacks
directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
NetApp sticks with full-year forecast amid ‘challenging macroeconomic environment’Cloud-services provider NetApp Inc. on Wednesday forecast second-quarter profit and sales that came in above expectations, but the company stuck with its...
Read more »
CBDCs seen offering faster settlements by 87% global securities firms: Citi surveyInstitutional investors, banks and asset managers have the greatest ability to scale and deliver market-wide solutions, a crucial determinant to the widespread adoption of CBDCs, stablecoins and other centrally governable financial instruments.
Read more »
Citi mulling further reorganization under CEO Jane Fraser: reportsCiti may eliminate positions as it mulls further changes after putting its overseas retail operations on the selling block and eliminating jobs across the bank.
Read more »
Lowe's, Zoom, Microsoft rise premarket; Macy's, Dick's Sporting Goods fall By Investing.comLowe's, Zoom, Microsoft rise premarket; Macy's, Dick's Sporting Goods fall
Read more »
Carl Ichan’s investing arm’s stock slides 4.2% to close to its 52-week lowIcahn Enterprises L.P.’s stock was down 4.2% to $19.86 on Tuesday, bringing it within sight of its its 52-week low of $18.03, hit earlier this year after...
Read more »
SELECT trial data a 'significant catalyst' for Novo Nordisk - Morgan Stanley By Investing.comSELECT trial data a 'significant catalyst' for Novo Nordisk - Morgan Stanley
Read more »